A citation-based method for searching scientific literature

R C Bast, T L Klug, E St John, E Jenison, J M Niloff, H Lazarus, R S Berkowitz, T Leavitt, C T Griffiths, L Parker, V R Zurawski, R C Knapp. N Engl J Med 1983
Times Cited: 1853







List of co-cited articles
578 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Reactivity of a monoclonal antibody with human ovarian carcinoma.
R C Bast, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp. J Clin Invest 1981
17

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
472
16

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
712
13

Ovarian cancer statistics, 2018.
Lindsey A Torre, Britton Trabert, Carol E DeSantis, Kimberly D Miller, Goli Samimi, Carolyn D Runowicz, Mia M Gaudet, Ahmedin Jemal, Rebecca L Siegel. CA Cancer J Clin 2018
957
13

MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis.
Catherine Thériault, Maxime Pinard, Marina Comamala, Martine Migneault, Julie Beaudin, Isabelle Matte, Marianne Boivin, Alain Piché, Claudine Rancourt. Gynecol Oncol 2011
109
11

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.
Richard G Moore, D Scott McMeekin, Amy K Brown, Paul DiSilvestro, M Craig Miller, W Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C Bast, Steven J Skates. Gynecol Oncol 2009
469
11


Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
10

Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
Beatrice W T Yin, Ann Dnistrian, Kenneth O Lloyd. Int J Cancer 2002
162
10


Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
Ronny Drapkin, Hans Henning von Horsten, Yafang Lin, Samuel C Mok, Christopher P Crum, William R Welch, Jonathan L Hecht. Cancer Res 2005
347
9

Factors influencing serum CA125II levels in healthy postmenopausal women.
D K Pauler, U Menon, M McIntosh, H L Symecko, S J Skates, I J Jacobs. Cancer Epidemiol Biomarkers Prev 2001
87
10

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.
Mildred Felder, Arvinder Kapur, Jesus Gonzalez-Bosquet, Sachi Horibata, Joseph Heintz, Ralph Albrecht, Lucas Fass, Justanjyot Kaur, Kevin Hu, Hadi Shojaei,[...]. Mol Cancer 2014
195
9

CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
Estrid V S Høgdall, Lise Christensen, Susanne K Kjaer, Jan Blaakaer, Anette Kjaerbye-Thygesen, Simon Gayther, Ian J Jacobs, Claus K Høgdall. Gynecol Oncol 2007
79
10

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
Daniel W Cramer, Robert C Bast, Christine D Berg, Eleftherios P Diamandis, Andrew K Godwin, Patricia Hartge, Anna E Lokshin, Karen H Lu, Martin W McIntosh, Gil Mor,[...]. Cancer Prev Res (Phila) 2011
194
8

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov, Malaika Amneus, Feng Su, Jennifer Lang, Jo Marie Tran Janco, Srinivasa T Reddy, Robin Farias-Eisner. Am J Obstet Gynecol 2008
188
8

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter, Jeffrey A Ledbetter, Michèl Schummer, Martin McIntosh, Charles Drescher, Nicole Urban, Karl Erik Hellström. Cancer Res 2003
466
8



Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion.
Armin Rump, Yoshihiro Morikawa, Minoru Tanaka, Sawako Minami, Naohiko Umesaki, Masaki Takeuchi, Atsushi Miyajima. J Biol Chem 2004
351
7

Ovarian cancer development and metastasis.
Ernst Lengyel. Am J Pathol 2010
840
7

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
Richard G Moore, Amy K Brown, M Craig Miller, Steven Skates, W Jeffrey Allard, Thorsten Verch, Margaret Steinhoff, Geralyn Messerlian, Paul DiSilvestro, C O Granai,[...]. Gynecol Oncol 2008
416
7

Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.
S E Kabawat, R C Bast, A K Bhan, W R Welch, R C Knapp, R B Colvin. Int J Gynecol Pathol 1983
531
7

The CA 125 gene: an extracellular superstructure dominated by repeat sequences.
T J O'Brien, J B Beard, L J Underwood, R A Dennis, A D Santin, L York. Tumour Biol 2001
200
7

Cancer of the ovary.
Stephen A Cannistra. N Engl J Med 2004
6

MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.
Jennifer A A Gubbels, Mildred Felder, Sachi Horibata, Jennifer A Belisle, Arvinder Kapur, Helen Holden, Sarah Petrie, Martine Migneault, Claudine Rancourt, Joseph P Connor,[...]. Mol Cancer 2010
102
6

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
Jennifer A A Gubbels, Jennifer Belisle, Masanori Onda, Claudine Rancourt, Martine Migneault, Mitchell Ho, Tapan K Bera, Joseph Connor, Bangalore K Sathyanarayana, Byungkook Lee,[...]. Mol Cancer 2006
237
6

New tumor markers: CA125 and beyond.
R C Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, K A Baggerly, E N Atkinson, S Skates, Z Zhang,[...]. Int J Gynecol Cancer 2005
340
6

Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
Manish S Patankar, Yu Jing, Jamie C Morrison, Jennifer A Belisle, Frank A Lattanzio, Yuping Deng, Nyet Kui Wong, Howard R Morris, Anne Dell, Gary F Clark. Gynecol Oncol 2005
103
6

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Martin Köbel, Steve E Kalloger, Niki Boyd, Steven McKinney, Erika Mehl, Chana Palmer, Samuel Leung, Nathan J Bowen, Diana N Ionescu, Ashish Rajput,[...]. PLoS Med 2008
555
6

Epidemiology of ovarian cancer: a review.
Brett M Reid, Jennifer B Permuth, Thomas A Sellers.  2017
446
6

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.
Frederick R Ueland, Christopher P Desimone, Leigh G Seamon, Rachel A Miller, Scott Goodrich, Iwona Podzielinski, Lori Sokoll, Alan Smith, John R van Nagell, Zhen Zhang. Obstet Gynecol 2011
130
6

Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Daniel G Rosen, Lin Wang, J Neeley Atkinson, Yinhua Yu, Karen H Lu, Eleftherios P Diamandis, Ingegerd Hellstrom, Samuel C Mok, Jinsong Liu, Robert C Bast. Gynecol Oncol 2005
249
6


MUC16: molecular analysis and its functional implications in benign and malignant conditions.
Dhanya Haridas, Moorthy P Ponnusamy, Seema Chugh, Imayavaramban Lakshmanan, Parthasarathy Seshacharyulu, Surinder K Batra. FASEB J 2014
56
10


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
6

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
6

Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
6

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Usha Menon, Andy Ryan, Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Anne Dawnay, Mariam Habib, Sophia Apostolidou, Naveena Singh, Elizabeth Benjamin, Matthew Burnell,[...]. J Clin Oncol 2015
116
5

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.
Kathryn L Terry, Helena Schock, Renée T Fortner, Anika Hüsing, Raina N Fichorova, Hidemi S Yamamoto, Allison F Vitonis, Theron Johnson, Kim Overvad, Anne Tjønneland,[...]. Clin Cancer Res 2016
46
10


Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
Antonio Santillan, Ruchi Garg, Marianna L Zahurak, Ginger J Gardner, Robert L Giuntoli, Deborah K Armstrong, Robert E Bristow. J Clin Oncol 2005
102
5

The role of CA125 in clinical practice.
E L Moss, J Hollingworth, T M Reynolds. J Clin Pathol 2005
159
5

CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells.
Silke Reinartz, Sophie Failer, Tina Schuell, Uwe Wagner. Eur J Cancer 2012
40
12

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass.
Richard G Moore, Moune Jabre-Raughley, Amy K Brown, Katina M Robison, M Craig Miller, W Jeffery Allard, Robert J Kurman, Robert C Bast, Steven J Skates. Am J Obstet Gynecol 2010
161
5


Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Simona Ferraro, Federica Braga, Monica Lanzoni, Patrizia Boracchi, Elia Mario Biganzoli, Mauro Panteghini. J Clin Pathol 2013
105
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.